CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Roberta Zappasodi(Cornell University), Taha Merghoub(Cornell University)
Cited by 389
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
|Nature|2017|1.2k
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
|Nature|2021|546
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
|Cell|2020|360
Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
|Cancer Research|2014|310